Apimeds Pharmaceuticals US, Inc. — SCHEDULE 13D/A Filings
2 SCHEDULE 13D/A filings on record
This page lists all SCHEDULE 13D/A filings submitted to the SEC by Apimeds Pharmaceuticals US, Inc. (APUS), sorted by most recent first. Each row links to the full filing on EdgarLookup. Apimeds Pharmaceuticals US, Inc. has filed 2 SCHEDULE 13D/A documents with the SEC since 2024. To view all SEC filings by Apimeds Pharmaceuticals US, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
3
3/A
4
4/A
424B4
425
8-A12B
8-K
8-K/A
CERT
CORRESP
DEFM14C
DRS
DRS/A
DRSLTR
EFFECT
FWP
NT 10-K
NT 10-Q
POS AM
PREM14C
S-1
S-1/A
S-8
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13D/A | — | 0001213900-26-032480 | Mar 20, 2026 | — |
| SCHEDULE 13D/A | — | 0001213900-26-007438 | Jan 26, 2026 | — |